Position in NVS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$4,531,715
-$2,153,388 QoQ
Shares Held
28,916
-33.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#278
of 1,603 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Private Advisor Group, LLC holds $233,466,304 across 14 Drug Manufacturers - General names. NVS ranks #9 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
277,688 | $70,524,421 | |
| 2 | ABBV |
AbbVie Inc.
|
233,214 | $58,685,970 | |
| 3 | MRK |
Merck & Co., Inc.
|
266,566 | $34,253,731 | |
| 4 | AMGN |
Amgen Inc
|
55,311 | $20,029,219 | |
| 5 | PFE |
Pfizer Inc
|
744,034 | $17,916,338 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
194,227 | $11,191,359 | |
| 7 | AZN |
Astrazeneca PLC
|
30,398 | $5,764,068 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
43,759 | $5,528,512 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,531,715 | 28,916 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $6,685,103 | 43,765 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $5,663,423 | 41,078 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,309,136 | 41,400 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,978,351 | 41,140 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $4,346,605 | 38,990 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $3,943,195 | 40,522 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $4,492,221 | 39,056 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $4,093,174 | 38,448 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $3,616,928 | 37,392 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $3,798,996 | 37,625 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,966,937 | 38,945 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $3,853,853 | 38,191 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,562,424 | 38,722 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $4,008,100 | 44,181 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $3,318,064 | 43,653 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $6,688,605 | 79,127 | Shares | Sole | 2022-07-13 | |
| 2021-12-31 | $6,060,971 | 69,292 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $7,333,866 | 89,678 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $4,500,139 | 49,322 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,773,685 | 44,147 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $4,161,718 | 44,072 | Shares | Sole | 2021-04-01 | |
| 2020-09-30 | $3,239,173 | 37,249 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $3,243,196 | 37,133 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $2,613,335 | 31,696 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||